MedPath

Evaluation of Combination Cholesterol Treatments in Patients With High Cholesterol.

Phase 4
Completed
Conditions
Hyperlipidemia
Dyslipidemia
Registration Number
NCT00249938
Lead Sponsor
University of Colorado, Denver
Brief Summary

The purpose of this study is to see if combination therapy with a "statin" medication and two additional agents that work differently than "statin" medications can further lower the so-called "bad cholesterol." One therapy is a prescription drug approved by the Food and Drug Administration to treat high cholesterol (Welchol). The other therapy is Minute Maid Heart Wise orange juice. This study juice is available in supermarkets and contains plant sterols that have been shown to lower cholesterol.

Detailed Description

Coronary heart disease (CHD) is the primary cause of morbidity and mortality in the United States. Lowering LDL cholesterol in both patients with and without CHD reduces coronary events and death. Statin medications are the primary mechanism of lowering LDL cholesterol, but some patients do not reach their goal LDL with maximum tolerated statin doses and must utilize combination therapy to further lower cholesterol. Additionally, some patients prefer to utilize "natural" mechanisms to lower cholesterol. This prospective, double-blinded, randomized study will compare plant sterol (natural cholesterol treatment) with placebo in patients treated with combination statin and colesevelam therapy.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
60
Inclusion Criteria
  • Diagnosis of high cholesterol being treated with a statin
  • LDL cholesterol greater than 100
  • Ability to swallow large tablets
Read More
Exclusion Criteria
  • Diabetes
  • Use of other medications to treat high cholesterol
  • History of liver disease
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
LDL cholesterol
Secondary Outcome Measures
NameTimeMethod
Triglycerides, HDL cholesterol, total cholesterol, C-reactive protein, Apolipoprotein B

Trial Locations

Locations (1)

University of Colorado at Denver and Health Sciences Center

🇺🇸

Denver, Colorado, United States

© Copyright 2025. All Rights Reserved by MedPath